SEP 5, 2026 · JOURNAL ARTICLE
Ufasomal Nanocarriers for Enhanced Cardiac Delivery of Nifedipine: A Novel Strategy to Mitigate Doxorubicin-Induced Cardiotoxicity in Breast Cancer Therapy
Journal of Drug Targeting
Early-stage preclinical study in an animal model demonstrating formulation optimization and proof-of-concept for a nanocarrier delivery strategy; lacks human efficacy data and clinical outcomes.
Reported
Mucosal permeability enhancement…69.07%
Mucosal permeability fold-change…6.47-fold
Bioavailability enhancement (nasa…7.33-fold